5Maes BD, Evenepoel P, Kuypers D, et al. A prospective placebo- controlled randomized singer center study of mycophenolate mofetil treatment for IgA nephropathy : Lack of eclinical fficacy after two years. J Am Sco Nephrol,2001,12 : 114A.
6Tang S, Leung JCK, Tang AWC, et al. A prospective, randomized casecontrolled study on the efficacy of mycophenolatemofetil (MMF) for IgA nephropathy (IgAN) patients with persistent proteinuria despite angiotensin blockade. J Am Sco Nephrol,2003,14:752A-753A.
7Frisch G,Lin J, Rosenstock J,et al. Mycophenolate mofetil vs. placebo in patients at high risk for progressive IgA nephropathy : A double blind RCT. J Am Sco Nephrol,2003,14:753A.
8Maes BD, Oyen R, Claes K, et al. Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study. Kidney Inter,2004,65 : 1842-1849.
9Nowack R,Birck R,van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet, 1997,349 : 1774.
10Briggs WA,Choi MJ,Scheel PJ. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis,1998,31:213-217.
